Press Release: HTG : HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
TUCSON, Ariz., April 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.
Read full article »
HTG is an Arizona-based RNA platform that automates sample processing for molecular profiling applications.
Read more